Sakar Healthcare Ltd.
| BSE: 538377 | Sector: Health care |
| NSE: SAKAR | ISIN Code: INE732S01012 |
| BSE 05:30 | 01 Jan | Sakar Healthcare Ltd |
| NSE 00:00 | 20 May | 161.60 |
9.95 (6.56%) |
OPEN
156.10 |
HIGH
166.00 |
LOW
152.60 |
| OPEN | |
| PREVIOUS CLOSE | |
| VOLUME | |
| 52-Week high | 0.00 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 0 |
| Buy Price | |
| Buy Qty | |
| Sell Price | |
| Sell Qty |
Sakar Healthcare Ltd. (SAKAR) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 915.50 | 3.52 | 966.90 | 652.75 | 219655.91 |
| Divi's Lab. | 4306.60 | 2.53 | 5425.00 | 3790.00 | 114318.70 |
| Cipla | 978.60 | 4.32 | 1083.15 | 850.00 | 78953.45 |
| Dr Reddy's Labs | 4246.30 | 8.10 | 5613.65 | 3655.00 | 70666.92 |
| Apollo Hospitals | 3667.65 | 0.94 | 5930.70 | 3122.90 | 52733.47 |
| Gland Pharma | 3070.20 | -0.83 | 4350.00 | 2801.00 | 50535.49 |
| Piramal Enterp. | 1917.10 | 1.19 | 3013.00 | 1671.35 | 45751.59 |
| Torrent Pharma. | 2664.45 | 2.82 | 3304.45 | 2485.00 | 45087.82 |
| Biocon | 339.65 | 5.17 | 420.25 | 314.90 | 40778.38 |
| Abbott India | 17972.40 | -0.90 | 23902.30 | 15525.00 | 38191.35 |
| Zydus Lifesci. | 357.15 | 5.48 | 668.85 | 319.40 | 36561.45 |
| Max Healthcare | 374.60 | 1.81 | 472.60 | 205.00 | 36322.34 |
| Alkem Lab | 3001.30 | 2.87 | 4067.70 | 2835.00 | 35880.54 |
| Aurobindo Pharma | 557.85 | 6.68 | 1043.00 | 521.00 | 32684.43 |
| Laurus Labs | 574.45 | 2.53 | 723.55 | 433.20 | 30868.07 |
| Lupin | 638.40 | 0.58 | 1267.50 | 620.35 | 29015.28 |
| Glaxosmi. Pharma | 1543.60 | 1.30 | 1917.00 | 1433.05 | 26150.13 |
| Ipca Labs. | 989.00 | 2.53 | 1383.55 | 917.00 | 25090.93 |
| Syngene Intl. | 559.15 | 3.02 | 699.95 | 508.10 | 22445.96 |
| Pfizer | 4352.00 | 2.06 | 6164.80 | 4077.80 | 19910.40 |
Quick Links for Sakar Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
